Cargando…
Clinical Utility of Romosozumab in the Management of Osteoporosis: Focus on Patient Selection and Perspectives
As one of the most potent osteoanabolic agents with a unique mechanism of action, romosozumab has high efficacy for osteoporosis treatment. It is a monoclonal antibody against sclerostin, a natural inhibitor of the Wnt signaling pathway, and by inhibiting sclerostin, activation of Wnt signaling occu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762257/ https://www.ncbi.nlm.nih.gov/pubmed/36544862 http://dx.doi.org/10.2147/IJWH.S315184 |